| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Beone Medicines AG's insiders have reduced their positions by a net 31,028 shares worth roughly $11.3M. In the past 30 days, 0 insiders bought and 1 sold.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 397.9K | $141.25M | - | |
| Dir | 161.6K | $57.35M | - | |
| Other | 99.6K | $35.37M | - | |
| Dir | 83.7K | $29.72M | - | |
| Dir | 73.2K | $25.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2020 | Xiaobin Wu52 | President & Gm China | Sell | 4,000 | $300.00 | $1,200,000.00 | -100% | |
| Sep 29, 2020 | Jane Huang81 | CMO, Hematology | Sale+OE | 1,500 | $280.38 | $420,568.28 | - | |
| Sep 29, 2020 | John Oyler58 | Chief Executive Officer | Sell | 54,303 | $280.39 | $15,226,093.35 | -100% | |
| Sep 25, 2020 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sell | 5,000 | $280.42 | $1,402,116.31 | -100% | |
| Sep 25, 2020 | Xiaobin Wu52 | President & Gm China | Sell | 4,000 | $280.35 | $1,121,406.00 | -100% | |
| Sep 17, 2020 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sell | 5,000 | $260.27 | $1,301,355.95 | -100% | |
| Sep 17, 2020 | Xiaobin Wu52 | President & Gm China | Sell | 4,000 | $260.33 | $1,041,326.90 | -100% | |
| Sep 16, 2020 | John Oyler58 | Chief Executive Officer | Sell | 81,228 | $253.46 | $20,587,969.07 | -100% | |
| Sep 14, 2020 | Howard Liang59 | CFO & Chief Strategy Officer | Sale+OE | 14,000 | $250.27 | $3,503,763.52 | - | |
| Sep 3, 2020 | Jane Huang81 | CMO, Hematology | Sell | 3,128 | $233.07 | $729,045.04 | -100% |